Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 7SS27 | IM |
was given wrong vaccine without side effects; This non-serious case was reported by other health professional and described the occurrence of wrong vaccine administered in a 19-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 7SS27, expiry date 31-OCT-2026) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis. Concomitant products included ethinylestradiol;norgestimate (Ortho Tri-Cyclen). On 28-AUG-2025, the patient received Menveo (intramuscular). The patient did not receive Bexsero. On 28-AUG-2025, an unknown time after receiving Menveo, the patient experienced wrong vaccine administered (Verbatim: was given wrong vaccine without side effects). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-SEP-2025 A patient was administered the wrong vaccine Menveo instead of Bexsero, but the patient did not experience any symptoms. No treatment was required, as no symptoms were reported. It was reported that patient had administered ortho tri cyclene for birth control.
ORTHO TRI-CYCLEN